January 5Ć5 Night at Start Garden
Voting Closes:
January 20, 2025 11:59 pm
Impact
GastroScreen has the potential to revolutionize the drug development process, leading to faster, safer, and more cost-effective treatments. Currently, 90% of drugs fail in clinical trials, wasting over $1 billion per drug and years of research, while leaving patients without new treatment options. By providing a more accurate model of the human intestine, GastroScreen can help reduce these costly failures, accelerate the development of life-saving therapies, and reduce the use of animals like mice, cats, dogs, and monkeys in research. Beyond drug testing, GastroScreen also shows promise for advancing research into gastrointestinal diseases and could one day support personalized medicine approaches for conditions like IBD and Crohn's Disease, benefiting millions worldwide.
What I'll do with $5,000
Intero Biosystems has been selected to be a featured startup company at multiple conferences including Chicago Biocaptial Summit, SLAS 2025, and more in the coming months. We will use the $5,000 to hone our conference booth setup, develop marketing materials, and secure travel to ensure we continue to make strong connections with potential customers and investors.